×
About 226 results

ALLMedicine™ Fibrolamellar Carcinoma Center

Research & Reviews  111 results

Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with H...
https://doi.org/10.1159/000513358
Oncology Gottlieb S, O'Grady C et. al.

Mar 10th, 2021 - There are no standard systemic therapies for the treatment of fibrolamellar carcinoma (FLC), as surgery remains the only definitive option. We share our experiences using systemic "triple therapy" (TT) with 5-fluorouracil, interferon, and nivoluma...

Fibrolamellar carcinoma: Challenging the challenge.
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.

Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...

Molecular profiling and analysis of genetic aberrations aimed at identifying potential ...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.

Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...

Fibrolamellar Carcinoma With Predominantly Pseudoglandular Architecture: A Potential Di...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP

Jun 8th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...

Fibrolamellar Carcinoma.
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA

Jun 4th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|

see more →

Clinicaltrials.gov  113 results

Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with H...
https://doi.org/10.1159/000513358
Oncology Gottlieb S, O'Grady C et. al.

Mar 10th, 2021 - There are no standard systemic therapies for the treatment of fibrolamellar carcinoma (FLC), as surgery remains the only definitive option. We share our experiences using systemic "triple therapy" (TT) with 5-fluorouracil, interferon, and nivoluma...

Fibrolamellar carcinoma: Challenging the challenge.
https://doi.org/10.1016/j.ejca.2020.06.035
European Journal of Cancer (Oxford, England : 1990); Lamarca A, Frizziero M et. al.

Aug 9th, 2020 - Fibrolamellar carcinoma (FLC) is a rare and poorly understood malignancy, which seems to be more prevalent in young patients compared with conventional hepatocellular carcinoma (HCC). Performing prospective clinical trials recruiting patients diag...

Molecular profiling and analysis of genetic aberrations aimed at identifying potential ...
https://doi.org/10.1002/cncr.32960
Cancer References; El Dika I, Bowman AS et. al.

Jul 14th, 2020 - Fibrolamellar carcinoma (FLC) is a rare primary liver cancer of young adults. A functional chimeric transcript resulting from the in-frame fusion of the DNAJ homolog, subfamily B, member 1 (DNAJB1), and the catalytic subunit of protein kinase A (P...

Fibrolamellar Carcinoma With Predominantly Pseudoglandular Architecture: A Potential Di...
https://doi.org/10.1177/1066896920933344
International Journal of Surgical Pathology; du Toit M, Aldera AP

Jun 8th, 2020 - Biopsies of liver mass lesions are encountered frequently in general surgical pathology practice. The clinical differential diagnosis is typically hepatocellular carcinoma (HCC) versus metastatic adenocarcinoma. There are a variety of HCC variants...

Fibrolamellar Carcinoma.
https://doi.org/10.1016/j.mayocp.2020.04.024
Mayo Clinic Proceedings; Erickson LA

Jun 4th, 2020 - Fibrolamellar Carcinoma.|2020|Erickson LA,|

see more →

News  2 results

MicroRNA-375 may be key to fibrolamellar carcinoma
https://www.mdedge.com/gihepnews/article/198920/liver-disease/microrna-375-may-be-key-fibrolamellar-carcinoma?channel=69
Will Pass, MDedge News

Apr 15th, 2019 - Up-regulation of microRNA-375 may be a future therapeutic strategy for patients with fibrolamellar carcinoma (FLC), according to investigators. Analysis of primary FLC tumors showed that microRNA-375 was the most abnormal microRNA, down-regulated.

38 Year Old Female With Worst Headache of Life
https://www.medscape.com/viewarticle/475293

May 17th, 2004 - Summary 38 year old female with worst headache of life. (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) A tumor of the liver associated with prior exposure to Thorotrast: Hemangioma Angiosarcoma FNH Fibrolamellar ca...

see more →